
Anthropic announced that its Claude agents identified a previously uncatalogued repeating DNA pattern surrounding a known enzyme, marking what the company calls its first scientific discovery. However, the claim has drawn sharp criticism from biologists who argue that finding such patterns is routine data analysis rather than a genuine scientific breakthrough. One biologist noted his team had already discovered this specific pattern, raising concerns about potential data contamination despite Anthropic's denial. The debate underscores the tension between AI companies' marketing of autonomous discovery and the scientific community's rigorous standards for what constitutes novel knowledge.
Read original
© WIRED AIAnthropic’s Claude identified a novel reverse transcriptase system in jumbo phages that resembles CRISPR, but the scientific community remains skeptical. While the speed of discovery is impressive, experts note the finding lacks wet-lab validation and may simply be pattern recognition on known data. The real story isn't a new gene-editing tool, but the opaque nature of how an AI model sifts through genomic databases to propose hypotheses that humans must still verify.
© Hugging Face BlogMost fact-checkers for AI agents only check if a claim is true in the evidence pool, ignoring where it came from. ProvenanceGuard fixes this by tracking source identity through every step of verification, catching cases where a true fact is wrongly attributed to the wrong tool or document. In medical agent tests, it caught 138 out of 139 incorrect attributions that standard verifiers missed, proving that provenance matters as much as truth in multi-tool environments. This shifts the focus from simple RAG retrieval to rigorous source-aware auditing for high-stakes applications.